Provider intervention associated with usage decline of high risk meds

Intervention impacts use of high-risk drugs in CMS Star metric

September 21, 2017

Intervention designed to impact use of high-risk medications evaluated as part of CMS Star metric

Prime sent letters to doctors to let them know they had prescribed high-risk medications to Medicare members. The intervention group’s high-risk medication percentage declined more than the control group. It was a statistically significant difference. Certain medications carry a greater risk of adverse events for the older adults than for younger people. Safer options exist for many high-risk medications.

Impact of First Fill Intervention on High-risk Medication Usage in a One Million Member Medicare Population (Fall 2016)

Related research

Scientific presentations

August 21, 2021

Real-world CAR-T treatment costs can range from $700,000 to $1 million

CAR-T treatment costs more than the CAR-T product itself; Prime’s real-world study of…

Scientific presentations

August 1, 2021

Prime’s analytics uncovers the hidden ups and downs behind the flat drug trend for MS DMDs

Insights from integrated medical and pharmacy claims show a big upswing in one…

Scientific presentations

June 21, 2021

Break autoimmune (AI) into indication-specific info for actionable strategy

Prime uses integrated medical and pharmacy data and breaks down largest drug category…